Jurisprudence and Ethics

Jurisprudence

and Business Ethics (Module 4)

A.O. No. 2015-053

​Implementing Guidelines on the Promotion and Marketing of Prescriptoin Pharmaceutical Products and Medical Devices

Multiple Choice

When was AO 2015-0053 signed?

• Dec 21, 2015

• February 10, 2016

• June 12, 2010

• June 24, 2015

Multiple Choice

When did AO 2015-0053 take effect?

• Dec 21, 2015

• February 10, 2016

• June 24, 2015

• September 24, 2015

Multiple Select

What Laws became the basis of AO no. 2015-003

• Consumer Act of the Philippines (RA 7394 Article 8)

• Food, Drug, and Cosmetic and Medical Device Act (RA 3720 as amended by EO 175 / RA 9711)

• The Generics Act (RA 6675)

• Universally Accessible and Affordable Quality Medicines Act (RA 9502)

• Mexico and Kuala Lumpur Principles

Anti Graft and Corrupt Practices Act (RA 3019 and RA 6713 Code of Conduct and Ethics for Public Officials and Employees

Uphold the values of integrity, accountability, transparency and good governance, affect the government’s commitment to a sustainable implementation of anti corruption measures and to exact the highest standards of integrity and professionalism in government processes and transactions

Multiple Select

What is the aim of the MCP/ KL principles?

• Reduce ethics compliance costs

• Provide a cost-effective way to access new APEC markets

• Self-Regulation

Multiple Choice

What is the scope of the MCP and KL Principles?

• Prescription Pharmaceutical Products and medical devices (PPPMD)

• Prescription Pharmaceutical Products Only

• Medical devices only